Current status of surgical treatment of rectal cancer in China

Yong Yang,Han-Yang Wang,Yong-Kang Chen,Jia-Jia Chen,Can Song,Jin Gu

DOI: https://doi.org/10.1097/cm9.0000000000001076

IF: 6.133

2020-09-03

Chinese Medical Journal

Abstract:<span>With the changing lifestyle and the acceleration of aging in the Chinese population, the incidence and mortality of colorectal cancer (CRC) have risen in the last decades. On the contrary, the incidence and mortality of CRC have continued to decline in the USA since the 1980s, which is mainly attributed to early screening and standardized diagnosis and treatment. Rectal cancer accounts for the largest proportion of CRC in China, and its treatment regimens are complex. At present, surgical treatment is still the most important treatment for rectal cancer. Since the first Chinese guideline for diagnosis and treatment of CRC was issued in 2010, the fourth version has been revised in 2020. These guidelines have greatly promoted the standardization and internationalization of CRC diagnosis and treatment in China. And with the development of comprehensive treatment methods such as neoadjuvant chemoradiotherapy, targeted therapy, and immunotherapy, the post-operative quality of life and prognosis of patients with rectal cancer have improved. We believe that the inflection point of the rising incidence and mortality of rectal cancer will appear in the near future in China. This article reviewed the current status and research progress on surgical therapy of rectal cancer in China.</span>

medicine, general & internal

What problem does this paper attempt to address?

This paper mainly discusses the current status and research progress of surgical treatment for rectal cancer in China. Specifically, the paper explores the following aspects:

1. **Background**: With changes in lifestyle and the acceleration of the aging process in the Chinese population, the incidence and mortality rates of rectal cancer have increased over the past few decades. In contrast, in the United States, the incidence and mortality rates of rectal cancer have been continuously declining since the 1980s due to early screening and standardized diagnosis and treatment measures.

2. **Incidence Trends and Overall Survival Rate**: The incidence and mortality rates of rectal cancer in China are increasing year by year, while the incidence and mortality rates of rectal cancer in the United States are showing a downward trend. The 5-year survival rate of rectal cancer in China is lower than that in the United States.

3. **Early Screening and Clinical Staging**: Early screening is crucial for reducing the incidence and mortality rates of rectal cancer. Although a higher proportion of the population in the United States has undergone rectal cancer screening, the prevalence of early screening in China is relatively low. The proportion of early rectal cancer diagnosis in China is far lower than in Japan and South Korea.

4. **Surgical Treatment**: Currently, surgery remains one of the most important treatment methods for rectal cancer. In recent years, with the development of diagnostic and therapeutic technologies, China's rectal cancer diagnosis and treatment guidelines have gradually aligned with international standards. The paper also provides a detailed introduction to the surgical treatment methods for different stages of rectal cancer, including endoscopic resection, local surgical resection, transanal endoscopic microsurgery (TEM), transanal minimally invasive surgery (TAMIS), etc., and discusses the role of neoadjuvant chemoradiotherapy and its impact on improving surgical outcomes.

5. **Comprehensive Treatment**: With the development of comprehensive treatment methods such as neoadjuvant chemotherapy, targeted therapy, and immunotherapy, the postoperative quality of life and prognosis of patients have significantly improved.

In summary, this paper aims to summarize the current status and development trends in the field of surgical treatment for rectal cancer in China, and emphasizes the importance of early screening, standardized treatment, and comprehensive treatment methods.